Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Oct;24(10):2555-60.
doi: 10.1007/s00198-013-2340-7. Epub 2013 Mar 28.

Multimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trial

M L Kilgore  1 , R Outman, J L Locher, J J Allison, A Mudano, B Kitchin, K G Saag, J R Curtis
Affiliations
Randomized Controlled Trial

Multimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trial

M L Kilgore et al. Osteoporos Int. 2013 Oct.

Abstract

Summary: We conducted a cluster randomized trial testing the effectiveness of an intervention to increase the use of osteoporosis medications in high-risk patients receiving home health care. The trial did not find a significant difference in medication use in the intervention arm.

Introduction: This study aims to test an evidence implementation intervention to improve the quality of care in the home health care setting for patients at high risk for fractures.

Methods: We conducted a cluster randomized trial of a multimodal intervention targeted at home care for high-risk patients (prior fracture or physician-diagnosed osteoporosis) receiving care in a statewide home health agency in Alabama. Offices throughout the state were randomized to receive the intervention or to usual care. The primary outcome was the proportion of high-risk home health patients treated with osteoporosis medications. A t test of difference in proportions was conducted between intervention and control arms and constituted the primary analysis. Secondary analyses included logistic regression estimating the effect of individual patients being treated in an intervention arm office on the likelihood of a patient receiving osteoporosis medications. A follow-on analysis examined the effect of an automated alert built into the electronic medical record that prompted the home health care nurses to deploy the intervention for high-risk patients using a pre-post design.

Results: There were 11 offices randomized to each of the treatment and control arms; these offices treated 337 and 330 eligible patients, respectively. Among the offices in the intervention arm, the average proportion of eligible patients receiving osteoporosis medications post-intervention was 19.1 %, compared with 15.7 % in the usual care arm (difference in proportions 3.4 %, 95 % CI, -2.6 to 9.5 %). The overall rates of osteoporosis medication use increased from 14.8 % prior to activation of the automated alert to 17.6 % afterward, a nonsignificant difference.

Conclusions: The home health intervention did not result in a significant improvement in use of osteoporosis medications in high-risk patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Rates of Osteoporosis Medication Use Pre-and Post-Intervention in Treatment and Usual care Offices
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465–475. - PubMed
    1. Kilgore ML, Morrisey MA, Becker DJ, Gary LC, Curtis JR, Saag KG, Yun H, Matthews R, Smith W, Taylor A, Arora T, Delzell E. Health Care Expenditures Associated with Skeletal Fractures Among Medicare Beneficiaries, 1999 - 2005. J Bone and Mineral Res. 2009 Dec;24(12):2050–5. - PubMed
    1. Curtis J, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E. Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc. 2010;11(8):584–91. - PMC - PubMed
    1. Lyles KW, Colón-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799–809. - PMC - PubMed
    1. McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L, Adekunle F, Roberts D. Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int. 2011 Jul;22(7):2083–98. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources